Crocus sativus L. extracts (saffron) are rich in
carotenoids. Preclinical studies have shown that dietary intake of
carotenoids has antitumor effects suggesting their potential preventive and/or therapeutic roles. We have recently reported that saffron (SE) and
crocin (CR) exhibit anticancer activity by promoting cell cycle arrest in
prostate cancer (PCa) cells. It has also been demonstrated that
crocetin esters are produced after SE gastrointestinal digestion by CR hydrolysis. The aim of the present report was to investigate if SE,
crocetin (CCT), and CR affected in vivo
tumor growth of two aggressive PCa cell lines (PC3 and 22rv1) which were xenografted in male nude mice treated by oral gavage with SE, CR, and CCT. We demonstrated that the antitumor effects of CCT were higher when compared to CR and SE and treatments reverted the epithelial-mesenchymal transdifferentiation (EMT) as attested by the significant reduction of
N-cadherin and
beta-catenin expression and the increased expression of
E-cadherin. Additionally, SE, CR, and CCT inhibited PCa cell invasion and migration through the downmodulation of
metalloproteinase and
urokinase expression/activity suggesting that these agents may affect metastatic processes. Our findings suggest that CR and CCT may be
dietary phytochemicals with potential antitumor effects in biologically aggressive PCa cells.